Bolt Biotherapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Bolt Biotherapeutics stock have an average target of 1.13, with a low estimate of 1.00 and a high estimate of 1.25. The average target predicts an increase of 182.50% from the current stock price of 0.40.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$1.13	$1.25	$1.25
Change	+150.00%	+182.50%	+212.50%	+212.50%

Analyst Ratings

The average analyst rating for Bolt Biotherapeutics stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	5	5	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 25, 2025
Stephen Willey Stifel	Stifel	Hold Maintains $1.5 → $1.25	Hold	Maintains	$1.5 → $1.25	+212.50%	Mar 25, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 13, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 15, 2024
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $3 → $1	Buy → Hold	Downgrades	$3 → $1	+150.00%	May 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

4.64M

from 7.69M

-39.73%

from 7.69M

Revenue Next Year

7.30M

from 4.64M

57.54%

from 4.64M

EPS This Year

-1.14

from -1.65

EPS Next Year

-0.86

from -1.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	231.00K	1.26M	5.73M	7.88M	7.69M	4.64M	7.30M	11.93M
Revenue Growth	7.44%	445.46%	354.68%	37.48%	-2.36%	-39.73%	57.54%	63.43%
EPS	-28.89	-2.97	-2.36	-1.83	-1.65	-1.14	-0.86	-0.35
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	9.3M	12.8M	36.8M
Avg	4.6M	7.3M	11.9M
Low	980,000	294,000	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	20.8%	175.3%	403.3%
Avg	-39.7%	57.5%	63.4%
Low	-87.3%	-93.7%	-

EPS Forecast

EPS	2025	2026	2027
High	-0.99	-0.78	-0.36
Avg	-1.14	-0.86	-0.35
Low	-1.41	-0.97	-0.33

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.